M2 Tumor‐Associated Macrophages‐Derived Exosomal MALAT1 Promotes Glycolysis and Gastric Cancer Progression
Advanced Science · 2024-06 · 11 (24)
DOI: 10.1002/advs.202309298 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 19.04.2024. Verfasst von Yanzheng Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, 212013, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, RNA, Long Noncoding, Glycolysis, Tumor-Associated Macrophages. Die Arbeit wurde bisher 122-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Distinguished Young Scholar Project of Jiangsu Province, Key Laboratory of Molecular Diagnostics and Precision Medicine for Surgical Oncology in Gansu Province.
Abstract (Originalsprache)
M2‐polarized tumor‐associated macrophages (M2 TAMs) promote cancer progression. Exosomes mediate cellular communication in the tumor microenvironment (TME). However, the roles of exosomes from M2 TAMs in gastric cancer progression are unclear. Herein, it is reported that M2 TAMs‐derived exosomes induced aerobic glycolysis in gastric cancer cells and enhanced their proliferation, metastasis, and chemoresistance in a glycolysis‐dependent manner. It is identified that MALAT1 (metastasis‐associated lung adenocarcinoma transcript 1) is enriched in M2 TAM exosomes and confirmed that MALAT1 transfer from M2 TAMs to gastric cancer cells via exosomes mediates this effect. Mechanistically, MALAT1 interacted with the δ‐catenin protein and suppressed its ubiquitination and degradation by β‐TRCP. In addition, MALAT1 upregulated HIF‐1α expression by acting as a sponge for miR‐217‐5p. The activation of β‐catenin and HIF‐1α signaling pathways by M2 TAM exosomes collectively led to enhanced aerobic glycolysis in gastric cancer cells. Finally, a dual‐targeted inhibition of MALAT1 in both gastric cancer cells and macrophages by exosome‐mediated delivery of siRNA remarkably suppressed gastric cancer growth and improved chemosensitivity in mouse tumor models. Taken together, these results suggest that M2 TAMs‐derived exosomes promote gastric cancer progression via MALAT1 ‐mediated regulation of glycolysis. The findings offer a potential target for gastric cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, 212013, China.
- Jiangsu Key Laboratory of Molecular Medicine, Medical School of Nanjing University, Nanjing, 210000, China.
- Department of Clinical Laboratory Medicine, Nantong Tumor Hospital/Affiliated Tumor Hospital of Nantong University, Nantong, 226300, China.
ORCID-Profile: Xu Zhang
Förderung
- National Natural Science Foundation of China
- Distinguished Young Scholar Project of Jiangsu Province
- Key Laboratory of Molecular Diagnostics and Precision Medicine for Surgical Oncology in Gansu Province
- Chinese Academy of Medical Sciences
- Zhenjiang Policy Guidance Program for International Science and Technology Cooperation
Zitieren
APA
Wang, Y., Zhang, J., Shi, H., Wang, M., Yu, D., Fu, M., Qian, Y., Zhang, X., Ji, R., Wang, S., Gu, J., & Zhang, X. (2024). M2 Tumor‐Associated Macrophages‐Derived Exosomal MALAT1 Promotes Glycolysis and Gastric Cancer Progression. Advanced Science, 11(24). https://doi.org/10.1002/advs.202309298
Vancouver
Wang Y, Zhang J, Shi H, Wang M, Yu D, Fu M, et al. M2 Tumor‐Associated Macrophages‐Derived Exosomal MALAT1 Promotes Glycolysis and Gastric Cancer Progression. Advanced Science. 2024;11(24). doi:10.1002/advs.202309298
BibTeX
@article{Wang2024,
author = {Wang, Yanzheng and Zhang, Jiahui and Shi, Hui and Wang, Maoye and Yu, Dan and Fu, Min and Qian, Yu and Zhang, Xiaoxin and Ji, Runbi and Wang, Shouyu and Gu, Jianmei and Zhang, Xu},
title = {M2 Tumor‐Associated Macrophages‐Derived Exosomal MALAT1 Promotes Glycolysis and Gastric Cancer Progression},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {24},
doi = {10.1002/advs.202309298}
}
EUVIMED